Design Therapeutics, Inc(NASDAQ:DSGN) 
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. T...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.41
H 3.66
L 3.29
C 3.40
V 114,421
10EMA 3.40
20EMA 3.40
60EMA 3.40
120EMA 3.40
250EMA 3.40